Prior administration of a non-steroidal anti-androgen failed to prevent the flare-up caused by a luteinizing hormone-releasing hormone agonist in a patient with metastatic prostate cancer

BACKGROUND: ‘Flare phenomenon’ after initial luteinizing hormone-releasing hormone agonist administration is a widely approved concept in the treatment of prostate cancer. In most guidelines, concomitant therapy with anti-androgens is recommended to prevent this flare phenomenon. However, there are...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Res Notes
Hlavní autoři: Uehara, Sho, Yuasa, Takeshi, Fujii, Yasuhisa, Yano, Akihiro, Yamamoto, Shinya, Masuda, Hitoshi, Fukui, Iwao, Yonese, Junji
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2015
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4526290/
https://ncbi.nlm.nih.gov/pubmed/26242866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-015-1297-3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky